4. 4. 3. 2 This TUE application must be:
- carried out respecting the Rower’s right to privacy
- fully medically justified
- submitted in English or French (including all medical
justifications), using the WADA web-based database
management system ADAMS including all the
medical justifications required and the signature
and contact details of the doctor who completed the
TUE.
4. 4. 3. 3 The approved TUE should never put the Rower at risk
of worsening his health condition and should be for a
specified duration.
4. 4. 3.4In an acute situation or emergency requiring
the use of a medication which would normally
require a TUE, the medical decision shall be made
by the FISA Medical Delegate at the regatta or,
in his or her absence, the regatta doctor. After
the regatta, an accelerated TUE process will be
followed and a TUE submitted to FISA within
7 days following the acute situation. The TUE
Committee will assess the validity of the situation
and the use (retroactive and /or future) of the
prohibited substance.
4. 4. 4 WADA, at the request of a Rower or on its own initiation,
may review the granting or denial of any by FISA. If WADA
determines that the granting or denial of a TUE did not
comply with the International Standard for Therapeutic
Use Exemptions in force at the time then WADA may reverse
that decision. Decisions on TUE’s are subject to further
appeal as provided in Article 13 of these Bye-Laws.
AR TICLE 5 – TESTING
5. 1 Authority to Test
All Rowers under the jurisdiction of a National Federation shall be
subject to In-Competition Testing by FISA, the Rower’s National
Federation, and any other Anti-Doping Organization responsible
